rs61990292

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4BP6_Very_StrongBA1

The NM_013382.7(POMT2):​c.1891+49C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0569 in 1,567,636 control chromosomes in the GnomAD database, including 3,034 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.042 ( 208 hom., cov: 32)
Exomes 𝑓: 0.059 ( 2826 hom. )

Consequence

POMT2
NM_013382.7 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.50

Publications

2 publications found
Variant links:
Genes affected
POMT2 (HGNC:19743): (protein O-mannosyltransferase 2) The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT1 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS).[provided by RefSeq, Oct 2008]
POMT2 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • myopathy caused by variation in POMT2
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal recessive limb-girdle muscular dystrophy type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with cerebellar involvement
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscle-eye-brain disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.184).
BP6
Variant 14-77279774-G-A is Benign according to our data. Variant chr14-77279774-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0631 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POMT2NM_013382.7 linkc.1891+49C>T intron_variant Intron 18 of 20 ENST00000261534.9 NP_037514.2 Q9UKY4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POMT2ENST00000261534.9 linkc.1891+49C>T intron_variant Intron 18 of 20 1 NM_013382.7 ENSP00000261534.4 Q9UKY4-1

Frequencies

GnomAD3 genomes
AF:
0.0418
AC:
6361
AN:
152066
Hom.:
208
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0115
Gnomad AMI
AF:
0.190
Gnomad AMR
AF:
0.0354
Gnomad ASJ
AF:
0.0311
Gnomad EAS
AF:
0.000968
Gnomad SAS
AF:
0.00849
Gnomad FIN
AF:
0.0501
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0647
Gnomad OTH
AF:
0.0402
GnomAD2 exomes
AF:
0.0414
AC:
8002
AN:
193232
AF XY:
0.0410
show subpopulations
Gnomad AFR exome
AF:
0.0104
Gnomad AMR exome
AF:
0.0268
Gnomad ASJ exome
AF:
0.0279
Gnomad EAS exome
AF:
0.000138
Gnomad FIN exome
AF:
0.0465
Gnomad NFE exome
AF:
0.0684
Gnomad OTH exome
AF:
0.0436
GnomAD4 exome
AF:
0.0585
AC:
82813
AN:
1415452
Hom.:
2826
Cov.:
30
AF XY:
0.0571
AC XY:
40141
AN XY:
702542
show subpopulations
African (AFR)
AF:
0.00913
AC:
297
AN:
32522
American (AMR)
AF:
0.0286
AC:
1137
AN:
39822
Ashkenazi Jewish (ASJ)
AF:
0.0267
AC:
677
AN:
25394
East Asian (EAS)
AF:
0.000211
AC:
8
AN:
37926
South Asian (SAS)
AF:
0.0110
AC:
906
AN:
82570
European-Finnish (FIN)
AF:
0.0432
AC:
2009
AN:
46520
Middle Eastern (MID)
AF:
0.0269
AC:
154
AN:
5722
European-Non Finnish (NFE)
AF:
0.0690
AC:
74900
AN:
1086010
Other (OTH)
AF:
0.0462
AC:
2725
AN:
58966
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4160
8319
12479
16638
20798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2744
5488
8232
10976
13720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0418
AC:
6361
AN:
152184
Hom.:
208
Cov.:
32
AF XY:
0.0412
AC XY:
3063
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.0115
AC:
477
AN:
41522
American (AMR)
AF:
0.0354
AC:
541
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0311
AC:
108
AN:
3470
East Asian (EAS)
AF:
0.000970
AC:
5
AN:
5152
South Asian (SAS)
AF:
0.00850
AC:
41
AN:
4824
European-Finnish (FIN)
AF:
0.0501
AC:
532
AN:
10612
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0647
AC:
4396
AN:
67988
Other (OTH)
AF:
0.0398
AC:
84
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
312
624
937
1249
1561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0490
Hom.:
67
Bravo
AF:
0.0402
Asia WGS
AF:
0.00606
AC:
22
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 01, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
5.4
DANN
Benign
0.88
PhyloP100
1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61990292; hg19: chr14-77746117; API